172 related articles for article (PubMed ID: 32111605)
21. Effects of glycogen synthase kinase 3beta and cyclin-dependent kinase 5 inhibitors on morphine-induced analgesia and tolerance in rats.
Parkitna JR; Obara I; Wawrzczak-Bargiela A; Makuch W; Przewlocka B; Przewlocki R
J Pharmacol Exp Ther; 2006 Nov; 319(2):832-9. PubMed ID: 16902054
[TBL] [Abstract][Full Text] [Related]
22. A bivalent compound targeting CCR5 and the mu opioid receptor treats inflammatory arthritis pain in mice without inducing pharmacologic tolerance.
Dutta R; Lunzer MM; Auger JL; Akgün E; Portoghese PS; Binstadt BA
Arthritis Res Ther; 2018 Jul; 20(1):154. PubMed ID: 30053832
[TBL] [Abstract][Full Text] [Related]
23. Role of Neuroinflammation in Opioid Tolerance: Translational Evidence from Human-to-Rodent Studies.
Lin CP; Lu DH
Adv Exp Med Biol; 2018; 1099():125-139. PubMed ID: 30306520
[TBL] [Abstract][Full Text] [Related]
24. Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy.
Kwiatkowski K; Pawlik K; Ciapała K; Piotrowska A; Makuch W; Mika J
Front Immunol; 2020; 11():615327. PubMed ID: 33408720
[TBL] [Abstract][Full Text] [Related]
25. The inhibition of the nitric oxide-cGMP-PKG-JNK signaling pathway avoids the development of tolerance to the local antiallodynic effects produced by morphine during neuropathic pain.
Hervera A; Leánez S; Pol O
Eur J Pharmacol; 2012 Jun; 685(1-3):42-51. PubMed ID: 22546233
[TBL] [Abstract][Full Text] [Related]
26. Clinical opioids differentially induce co-internalization of μ- and δ-opioid receptors.
Bao F; Li CL; Chen XQ; Lu YJ; Bao L; Zhang X
Mol Pain; 2018; 14():1744806918769492. PubMed ID: 29587571
[TBL] [Abstract][Full Text] [Related]
27. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance.
Xie JY; Herman DS; Stiller CO; Gardell LR; Ossipov MH; Lai J; Porreca F; Vanderah TW
J Neurosci; 2005 Jan; 25(2):409-16. PubMed ID: 15647484
[TBL] [Abstract][Full Text] [Related]
28. Involvement of kappa opioid receptors in formalin-induced inhibition of analgesic tolerance to morphine in mice.
Tokuyama S; Nagae R; Mashida E; Hamabe W
J Pharm Pharmacol; 2007 Aug; 59(8):1109-15. PubMed ID: 17725853
[TBL] [Abstract][Full Text] [Related]
29. Telmisartan Is a Promising Agent for Managing Neuropathic Pain and Delaying Opioid Analgesic Tolerance in Rats.
Karádi DÁ; Galambos AR; Lakatos PP; Apenberg J; Abbood SK; Balogh M; Király K; Riba P; Essmat N; Szűcs E; Benyhe S; Varga ZV; Szökő É; Tábi T; Al-Khrasani M
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175678
[TBL] [Abstract][Full Text] [Related]
30. TGF-β and opioid receptor signaling crosstalk results in improvement of endogenous and exogenous opioid analgesia under pathological pain conditions.
Lantero A; Tramullas M; Pílar-Cuellar F; Valdizán E; Santillán R; Roques BP; Hurlé MA
J Neurosci; 2014 Apr; 34(15):5385-95. PubMed ID: 24719115
[TBL] [Abstract][Full Text] [Related]
31. Sigma-1 receptor modulates neuroinflammation associated with mechanical hypersensitivity and opioid tolerance in a mouse model of osteoarthritis pain.
Carcolé M; Kummer S; Gonçalves L; Zamanillo D; Merlos M; Dickenson AH; Fernández-Pastor B; Cabañero D; Maldonado R
Br J Pharmacol; 2019 Oct; 176(20):3939-3955. PubMed ID: 31332781
[TBL] [Abstract][Full Text] [Related]
32. Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia.
Hutchinson MR; Coats BD; Lewis SS; Zhang Y; Sprunger DB; Rezvani N; Baker EM; Jekich BM; Wieseler JL; Somogyi AA; Martin D; Poole S; Judd CM; Maier SF; Watkins LR
Brain Behav Immun; 2008 Nov; 22(8):1178-89. PubMed ID: 18599265
[TBL] [Abstract][Full Text] [Related]
33. A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine.
Johnston IN; Milligan ED; Wieseler-Frank J; Frank MG; Zapata V; Campisi J; Langer S; Martin D; Green P; Fleshner M; Leinwand L; Maier SF; Watkins LR
J Neurosci; 2004 Aug; 24(33):7353-65. PubMed ID: 15317861
[TBL] [Abstract][Full Text] [Related]
34. Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance.
Trang T; Sutak M; Jhamandas K
Neuroscience; 2007 May; 146(3):1275-88. PubMed ID: 17395382
[TBL] [Abstract][Full Text] [Related]
35. Attenuation of opioid analgesic tolerance in p75 neurotrophin receptor null mutant mice.
Trang T; Koblic P; Kawaja M; Jhamandas K
Neurosci Lett; 2009 Feb; 451(1):69-73. PubMed ID: 19114089
[TBL] [Abstract][Full Text] [Related]
36. Blockade of CC Chemokine Receptor Type 3 Diminishes Pain and Enhances Opioid Analgesic Potency in a Model of Neuropathic Pain.
Pawlik K; Ciechanowska A; Ciapała K; Rojewska E; Makuch W; Mika J
Front Immunol; 2021; 12():781310. PubMed ID: 34795678
[TBL] [Abstract][Full Text] [Related]
37. Involvement of kappa opioid receptors in the formalin-induced inhibition of analgesic tolerance to morphine via suppression of conventional protein kinase C activation.
Fujita-Hamabe W; Nagae R; Nawa A; Harada S; Nakamoto K; Tokuyama S
J Pharm Pharmacol; 2010 Aug; 62(8):995-1002. PubMed ID: 20663033
[TBL] [Abstract][Full Text] [Related]
38. Magnitude of acute tolerance to opioids is not related to their potency.
Kissin I; Brown PT; Bradley EL
Anesthesiology; 1991 Nov; 75(5):813-6. PubMed ID: 1659255
[TBL] [Abstract][Full Text] [Related]
39. Increased glutamate synaptic transmission in the nucleus raphe magnus neurons from morphine-tolerant rats.
Bie B; Pan ZZ
Mol Pain; 2005 Feb; 1():7. PubMed ID: 15813995
[TBL] [Abstract][Full Text] [Related]
40. Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance.
Largent-Milnes TM; Yamamoto T; Nair P; Moulton JW; Hruby VJ; Lai J; Porreca F; Vanderah TW
Br J Pharmacol; 2010 Nov; 161(5):986-1001. PubMed ID: 20977451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
